Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 61 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8916519

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  2. US 8916566

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  3. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  4. US 8912326

    Process of making gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  5. US 8912198

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  6. US 8906922

    Substituted triazoles useful as AXl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  7. US 8906901

    Administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  8. US 8901169

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  9. US 8901117

    Small molecule inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  10. US 8895740

    Pyrazolopyrazine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  11. US 8883818

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  12. US 8883771

    Bivalent inhibitors of IAP proteins and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  13. US 8877759

    Aminopyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted
  14. US 8871774

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  15. US 8871792

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  16. EP 2791134

    CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

    BIAL PORTELA & Cª S A [PT] · Granted Oct 22, 2014 · Expires Oct 17, 2034

    granted
  17. US 8865750

    Small molecule inhibitors of RGS proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  18. US 8865771

    Amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  19. US 8865751

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  20. US 8865745

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  21. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  22. US 8865728

    Combinations comprising methotrexate and DHODH inhibitors

    Almirall, S.A. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  23. US 8853244

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  24. US 8853427

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted